IMFINZI (Durvalumab) 120 mg Injection
IMFINZI Durvalumab 120 mg Injection is an advanced cancer immunotherapy medicine used in oncology treatment. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) blocking antibody that helps activate the immune system to recognize and destroy cancer cells more effectively. It is commonly used in the treatment of non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and certain biliary tract cancers, often as maintenance or combination therapy.
This medicine belongs to immune checkpoint inhibitor therapy and is designed to enhance the body’s natural immune response against cancer cells.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 120 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 proteins on cancer cells
- Reactivating immune T-cell response
- Helping the immune system identify and attack tumors
- Slowing cancer growth and progression
Uses and Treatments
IMFINZI (Durvalumab) 120 mg Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer
- Bladder and urothelial cancers (selected cases)
- Maintenance therapy after chemoradiation in lung cancer
Dosage and How to Use
- Administered as intravenous infusion only in hospital settings
- Given every 2–4 weeks depending on treatment protocol
- Dose is determined by oncologist based on body weight and condition
- Must be used under strict medical supervision
Advantages of IMFINZI (Durvalumab)
- Enhances immune system’s ability to fight cancer
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiotherapy
- Targeted immunotherapy with precise mechanism
- Helps delay cancer progression and recurrence
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vial
- For hospital/oncology use only
Alternative Indian Brands / Options
Durvalumab is a patented immunotherapy, so no direct Indian generic version exists. However, similar immune checkpoint inhibitors used in oncology include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Oncology biosimilars and supportive cancer medicines from Dr. Reddy’s Laboratories
All alternatives must be selected only under oncologist supervision.
Buy IMFINZI Durvalumab 120 mg Injection Online in India – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 120 mg Injection in India? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure delivery across India.
We supply advanced immunotherapy medicines used in modern cancer treatment protocols with strict pharmaceutical quality standards.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure delivery
- 100% genuine pharmaceutical products
- Reliable global healthcare supply chain
- Expert support for hospital procurement
- Buy Durvalumab 120 mg India
- IMFINZI injection price India
- Lung cancer immunotherapy India
- PD-L1 inhibitor medicine India
- Cancer immunotherapy injection India
- Oncology medicine exporter India
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across India!
